860900C

14:0-16:1-14:0 D5 TG

Avanti Research^™ - A Croda Brand 860900C

• Synonym(e): 1,3(d5)-ditetradecanoyl-2-(9Z-hexadecenoyl)-glycerol
• Empirische Formel (Hill-System): C₄₇H₈₃D₅O₆
• CAS-Nummer: 944709-23-3
• Molekulargewicht: 754.23
• UNSPSC-Code: 41116107
• NACRES: NA.12

Eigenschaften

• Form: liquid
• Verpackung: pkg of 1 × 1 mL (860900C-1mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 860900C
• Konzentration: 1 mg/mL (860900C-1mg)
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [2H]C(C([2H])([2H])OC(CCCCCCCCCCCCC)=O)(OC(CCCCCCC/C=C\CCCCCC)=O)C([2H])([2H])OC(CCCCCCCCCCCCC)=O

Beschreibung

Allgemeine Beschreibung

14:0-16:1-14:0 D5 TG, also known as 1,3(d5)-ditetradecanoyl-2-(9Z-hexadecenoyl)-glycerol, belongs to the class of prostaglandin deuterated isotopes.

Anwendung

14:0-16:1-14:0 D5 TG or 1,3(d5)-ditetradecanoyl-2-(9Z-hexadecenoyl)-glycerol has been used as an internal standard in mass spectrometry analysis of triacylglycerides. It has also been used as an internal standard in the extraction protocol to separate neutral lipids from polar lipids.

Verpackung

5 mL Clear Glass Sealed Ampule (860900C-1mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372
• P-Sätze: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system
• WGK: WGK 3